Academic Journal
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment
| العنوان: | Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment |
|---|---|
| المؤلفون: | Meerveld-Eggink, Aafke, Graafland, Niels, Wilgenhof, Sofie, Van Thienen, Johannes V., Lalezari, Ferry, Grant, Michael, Szabados, Bernadett, Abu-Ghanem, Yasmin, Kuusk, Teele, Boleti, Ekaterini, Blank, Christian U., Haanen, John B.A.G., Powles, Thomas, Bex, Axel |
| المساهمون: | AstraZeneca, Novartis, Bristol-Myers Squibb, Pfizer, Roche |
| المصدر: | European Urology Open Science ; volume 35, page 54-58 ; ISSN 2666-1683 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.euros.2021.11.003 |
| الاتاحة: | http://dx.doi.org/10.1016/j.euros.2021.11.003 https://api.elsevier.com/content/article/PII:S2666168321033802?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2666168321033802?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.556FC34E |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.euros.2021.11.003 |
|---|